EMUC 2020 GU Malignancies Non-Prostate

Viewing 1-20 of 23 articles

EMUC 2020: Hybrid ICG - 99mTc - Nanocolloid, on the Road Towards Becoming the New Standard for Sentinel Node Biopsy in Penile Cancer

EMUC 2020: Organ Preservation in Challenging Cases - Penile Cancer

EMUC 2020: A Subgroup Analysis from the IMvigor130 Study in Patients with Upper Tract vs. Lower Tract Locally Advanced or Metastatic Urothelial Carcinoma Treated with Atezolizumab plus Platinum - Based Chemotherapy

EMUC 2020: Adjuvant Strategies in Locally Advanced Bladder Cancer

EMUC 2020: Organ Preservation in Bladder Cancer (Trimodal vs Cystectomy)

EMUC 2020: Organ Preservation in Challenging Cases - Testicular Cancer

EMUC 2020: Molecular Sub-Staging of Bladder Cancer: Is It Really Useful?

EMUC 2020: Kidney Sparing in Upper Tract Urothelial Cancer

EMUC 2020: Partial Nephrectomy in T2 Tumors, Renal Cell Carcinoma

EMUC 2020: Neoadjuvant Versus Adjuvant Strategies in Locally Advanced Bladder Cancer

EMUC 2020: Management and Survival of Patients with Retroperitoneal Recurrences Following Radical Nephrectomy

EMUC 2020: Molecular Subtypes of Fully Resected Clear Cell Renal Cell Carcinoma Are Prognostic for Risk of Relapse and May Impact Adjuvant Treatment

EMUC 2020: VIRADS - Can We Avoid TUR-B Prior to Radical Cystectomy?

EMUC 2020: COVID-19 and GU Cancer Care: The Radiation Oncologist's Experience

EMUC 2020: The COVID-19 Pandemic: The Urologist's Experience

EMUC 2020: COVID-19 and GU Cancer Care: The Medical Oncologist's Experience

EMUC 2020: Optimal First Line Therapy in Metastatic Bladder Cancer Disease

EMUC 2020: Recommendations During COVID-19 from the EAU Guidelines Office Rapid Reaction Group

EMUC 2020: Durvalumab Monotherapy or in Combination with Tremelimumab Versus Standard of Care Chemotherapy in Patients with Advanced Urothelial Carcinoma, The DANUBE Trial

EMUC 2020: Standard BCG vs Reduced Frequency BCG in Non-Muscle Invasive Bladder Cancer, The NIMBUS Trial

1
2